A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension

Arnold, N. D., Pickworth, J. A., West, L. E., Dawson, S., Carvalho, J. A., Casbolt, H., Braithwaite, A. T., Iremonger, J., Renshall, L., Germaschewski, V., McCourt, M., Bland-Ward, P., Kowash, H., Hameed, A. G., Rothman, A. M. K., Frid, M. G., Roger Thompson, A. A., Evans, H. R., Southwood, M., Morrell, N. W. & 7 others, Crossman, D. C., Whyte, M. K. B., Stenmark, K. R., Newman, C. M., Kiely, D. G., Francis, S. E. & Lawrie, A., 15 Nov 2019, In : Nature Communications. 10, 18 p., 5183.

Research output: Contribution to journal › Article

Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial

Mullen, M., Jin, X. Y., Child, A., Stuart, A. G., Dodd, M., Aragon-Martin, J. A., Gaze, D., Kiotsekoglou, A., Yuan, L., Hu, J., Foley, C., Van Dyck, L., Knight, R., Clayton, T., Swan, L., Thomson, J. D. R., Erdem, G., Crossman, D., Flather, M. & AIMS Investigators, 21 Dec 2019, In : Lancet. 394, 10216, p. 2263-2270

Research output: Contribution to journal › Article

ATP evokes Ca²⁺ responses and CXCL5 secretion via P2X₄ receptor activation in human monocyte-derived macrophages

Layhadi, J. A., Turner, J., Crossman, D. & Fountain, S. J., 1 Feb 2018, In : The Journal of Immunology. 200, 3, p. 1159-1168

Research output: Contribution to journal › Article